CMPX: Compass Therapeutics, Inc. Stock

by  •  • Comments Off on CMPX: Compass Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 199.50
Enterprise Value ($M) 175.28
Book Value ($M) 148.54
Book Value / Share 1.08
Price / Book 1.34
NCAV ($M) 145.54
NCAV / Share 1.06
Price / NCAV 1.37

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.24

Liquidity (mrq)
Quick Ratio 19.73
Current Ratio 19.73

Balance Sheet (mrq) ($M)
Current Assets 153.88
Assets 156.88
Liabilities 8.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -50.36
Net Income -42.49
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -40.62
Cash from Investing 26.96
Cash from Financing 2.94

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-22 13D/A Orbimed Advisors Llc 13.70 0.00
02-09 13G/A Fmr Llc 3.57 -28.38
02-07 13G/A Adage Capital Partners Gp, L.l.c. 7.75 37.00
02-01 13G Janus Henderson Group Plc 6.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 1,393 40,316 3.46
2024-04-25 40,057 129,014 31.05
2024-04-24 8,041 68,188 11.79
2024-04-23 10,620 28,252 37.59
2024-04-22 13,167 32,528 40.48

(click for more detail)

Similar Companies
CLNN – Clene Inc. CLRB – Cellectar Biosciences, Inc.
CLVR – Clever Leaves Holdings Inc. CNSP – CNS Pharmaceuticals, Inc.
CNTX – Context Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io